Evaluating the Quality of Latent Tuberculosis Infection Screening in Ireland: A Single-Centre Retrospective Cohort Study
- PMID: 35202214
- PMCID: PMC8880574
- DOI: 10.3390/tropicalmed7020019
Evaluating the Quality of Latent Tuberculosis Infection Screening in Ireland: A Single-Centre Retrospective Cohort Study
Abstract
Ireland is a country with a low incidence of tuberculosis (TB) (5.6 cases per 100,000 population in 2019) that should be aiming for TB elimination (fewer than 1 case per million of population). To achieve TB elimination in low-incidence countries, programmatic latent tuberculosis infection (LTBI) management is important. This requires high-quality latent tuberculosis infection (LTBI) screening.
Aim: To assess the quality of LTBI screening in a tertiary centre in Ireland using a framework.
Methods: A retrospective review of the health care records of patients screened for TB in a tertiary centre in Ireland using an interferon-gamma release assay (IGRA) between 2016 and 2018 was performed. Three domains from the Institute of Medicine framework for health care quality, effectiveness, efficiency, and equity, were applied to measure the quality of LTBI screening.
Results: Forty patients had LTBI and an indication for treatment, of whom 20% (8/40) were not offered treatment by the health care provider, 2.5% (1/40) did not accept treatment, and 10% (4/40) did not complete treatment. Seventy-five percent (6/8) of patients not offered treatment were non-Irish. The cost of screening per LTBI case identified was EUR 2048.
Conclusions: This study evaluated the quality of LTBI screening using a framework and identified that LTBI screening in this tertiary centre needs to be scaled and expanded, and that treatment initiation needs to be improved, particularly among non-Irish nationals.
Keywords: cost analysis; effectiveness; equity; latent tuberculosis infection; quality of care.
Conflict of interest statement
The authors declare they have no conflict of interest.
Figures
Similar articles
-
Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.Eur J Health Econ. 2017 May;18(4):405-415. doi: 10.1007/s10198-016-0779-0. Epub 2016 Mar 12. Eur J Health Econ. 2017. PMID: 26970772
-
A Survey of Latent Tuberculosis Screening and Treatment Practices in a Tertiary Centre.Ir Med J. 2021 Aug 19;114(7):406. Ir Med J. 2021. PMID: 34520641
-
Comparing the cost-effectiveness of two screening strategies for latent tuberculosis infection in Portugal.Pulmonology. 2021 Nov-Dec;27(6):493-499. doi: 10.1016/j.pulmoe.2021.04.002. Epub 2021 May 27. Pulmonology. 2021. PMID: 34053903 Review.
-
Screening for Latent Tuberculosis Infection in Migrants With CKD: A Cost-effectiveness Analysis.Am J Kidney Dis. 2019 Jan;73(1):39-50. doi: 10.1053/j.ajkd.2018.07.014. Epub 2018 Sep 28. Am J Kidney Dis. 2019. PMID: 30269868
-
A clinical audit and cost analysis of latent TB management at a tertiary referral centre in Ireland.Ir J Med Sci. 2020 Nov;189(4):1163-1170. doi: 10.1007/s11845-020-02209-3. Epub 2020 Mar 18. Ir J Med Sci. 2020. PMID: 32189196 Review.
Cited by
-
Infection Prevention and Control: Practical and Educational Advances.Trop Med Infect Dis. 2022 Jul 26;7(8):148. doi: 10.3390/tropicalmed7080148. Trop Med Infect Dis. 2022. PMID: 35893656 Free PMC article.
References
-
- World Health Organisation Global Tuberculosis Report 2020. 2020. [(accessed on 5 August 2021)]. Available online: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-en....
-
- Lönnroth K., Migliori G.B., Abubakar I., D’Ambrosio L., De Vries G., Diel R., Douglas P., Falzon D., Gaudreau M.-A., Goletti D., et al. Towards tuberculosis elimination: An action framework for low-incidence countries. Eur. Respir. J. 2015;45:928–952. doi: 10.1183/09031936.00214014. - DOI - PMC - PubMed
-
- Walker T.M., Lalor M.K., Broda A., Ortega L.S., Morgan M., Parker L., Churchill S., Bennett K., Golubchik T., Giess A., et al. Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007–2012, with whole pathogen genome sequences: An observational study. Lancet Respir. Med. 2014;2:285–292. doi: 10.1016/S2213-2600(14)70027-X. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources